Skip to main content

ORIGINAL RESEARCH article

Front. Immunol., 24 March 2022
Sec. Microbial Immunology

PgtE Enzyme of Salmonella enterica Shares the Similar Biological Roles to Plasminogen Activator (Pla) in Interacting With DEC-205 (CD205), and Enhancing Host Dissemination and Infectivity by Yersinia pestis

Qiao Li&#x;Qiao Li1†Chenglin Ye&#x;Chenglin Ye2†Fei Zhao&#x;Fei Zhao1†Wenjin LiWenjin Li1Sizhe ZhuSizhe Zhu1Yin LvYin Lv1Chae Gyu Park,Chae Gyu Park3,4Yingmiao ZhangYingmiao Zhang1Ling-Yu JiangLing-Yu Jiang1Kun YangKun Yang1Yingxia HeYingxia He1Huahua CaiHuahua Cai1Song ZhangSong Zhang5Hong-Hui DingHong-Hui Ding1Olivia Adhiambo NjiriOlivia Adhiambo Njiri1John Mambwe TemboJohn Mambwe Tembo1Ayman Ahmad Alkraiem,Ayman Ahmad Alkraiem6,7An-Yi LiAn-Yi Li1Zi-Yong SunZi-Yong Sun1Wei LiWei Li8Mei-Ying YanMei-Ying Yan8Biao KanBiao Kan8Xixiang HuoXixiang Huo9John D. KlenaJohn D. Klena10Mikael SkurnikMikael Skurnik11Andrey P. AnisimovAndrey P. Anisimov12Xiaofang GaoXiaofang Gao13Yanping HanYanping Han13Rui-Fu YangRui-Fu Yang13Xiding XiamuXiding Xiamu14Yuanzhi WangYuanzhi Wang15Hongxiang ChenHongxiang Chen5Bao Chai,Bao Chai16,17Yicheng Sun*Yicheng Sun18*Jingping Yuan*Jingping Yuan2*Tie Chen*Tie Chen1*
  • 1Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, China
  • 2Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China
  • 3Therapeutic Antibody Research Center, Genuv Inc., Seoul, South Korea
  • 4Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University, Seoul, South Korea
  • 5Union Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, China
  • 6Tongji Hospital, Tongji Medical College, Huazhong University, Wuhan, China
  • 7Department of Biology, College of Science, Taibah University, Medina, Saudi Arabia
  • 8National Institute for Communicable Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
  • 9Center for Infectious Diseases, Hubei Provincial Centers for Disease Control and Prevention (CDC), Wuhan, China
  • 10Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States
  • 11Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
  • 12Laboratory for Plague Microbiology, State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia
  • 13State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
  • 14Division of Disease Control and Prevention for Endemic Diseases , Wenquan Center for Disease Control and Prevention, Wenquan, China
  • 15Department of Pathogen Biology and Immunology, Shihezi University School of Medicine, Shihezi, China
  • 16Department of Dermatology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China
  • 17Department of Dermatology, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China
  • 18Ministry of Health (MOH) Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Yersinia pestis, the cause of plague, is a newly evolved Gram-negative bacterium. Through the acquisition of the plasminogen activator (Pla), Y. pestis gained the means to rapidly disseminate throughout its mammalian hosts. It was suggested that Y. pestis utilizes Pla to interact with the DEC-205 (CD205) receptor on antigen-presenting cells (APCs) to initiate host dissemination and infection. However, the evolutionary origin of Pla has not been fully elucidated. The PgtE enzyme of Salmonella enterica, involved in host dissemination, shows sequence similarity with the Y. pestis Pla. In this study, we demonstrated that both Escherichia coli K-12 and Y. pestis bacteria expressing the PgtE-protein were able to interact with primary alveolar macrophages and DEC-205-transfected CHO cells. The interaction between PgtE-expressing bacteria and DEC-205-expressing transfectants could be inhibited by the application of an anti-DEC-205 antibody. Moreover, PgtE-expressing Y. pestis partially re-gained the ability to promote host dissemination and infection. In conclusion, the DEC-205-PgtE interaction plays a role in promoting the dissemination and infection of Y. pestis, suggesting that Pla and the PgtE of S. enterica might share a common evolutionary origin.

Introduction

Yersinia pestis, a Gram-negative bacterium, is the causative agent of bubonic, septicemic, and pneumonic plague (1). Y. pestis has been responsible for all three historical plague pandemics, including the Justinian, the Black Death, and the third pandemic (24), as well as one or more prehistoric plague pandemic (5, 6). The study by Rascovan et al. revealed a prehistoric plague pandemic between 6,000–5,000 BP that occurred at the same time with the decline of Neolithic populations in Europe and suggested that this pandemic caused by multiple lineages of Y. pestis expanded across Eurasia might result in the decline (6). As also summarized by the author, “Our results are consistent with the existence of a prehistoric plague pandemic that likely contributed to the decay of Neolithic populations in Europe” (6). This bacterial pathogen was also used as a biological weapon during the Second World War (7).

Y. pestis evolved from Yersina pseudotuberculosis within the last 2,600 to 28,000 years (4, 811), but each of them causes very different diseases in animals. Y. pseudotuberculosis typically transmitted through the fecal-oral route and primarily causes mesenteric lymphadenitis and self-limited diarrhea in the host (12). In contrast, Y. pestis causes in the host a highly fatal disease, known as the plague, in the host (1). Many comparative studies between Y. pestis and Y. pseudotuberculosis have been carried out to determine what are the virulence factors Y. pestis has acquired during evolution that have converted the mild pathogen Y. pseudotuberculosis to a highly virulent and deadly pathogen. Notably, the plasmid pPCP1 was one of them.

The plasmid pPCP1 was acquired by an ancestral strain after Pestoides F Y. pestis (do not carry pPCP1) in the evolution tree, during the divergence from Y. pseudotuberculosis into modern Y. pestis (1316). One key factor that promotes Y. pestis pathogenesis is plasminogen activator (Pla), which is encoded by the pPCP1 plasmid (17). Zimbler et al. even speculated that the ancestral strain, Pestoides F, was unable to cause primary pneumonic plague prior to the acquisition of Pla (16). Pla is required for the full virulence of Y. pestis in both bubonic and pneumonic plague but is not essential for the pathogenesis of septicemic plague (1824). These results have indicated that Pla may facilitate the dissemination of Y. pestis within hosts.

Studies have shown that Pla promotes the fibrinolysis, allowing the bacteria to disrupt tissue barriers at the subdermal injection sites either after a flea bite or experimental subdermal inoculation. This process facilitates the bacterial dissemination into the lymphatic tissue, liver, and spleen of the host (19, 21, 24). Because Pla belongs to a family of enteric bacterial outer membrane proteases, the bacterial species that initially harbored the Pla-encoding gene is thought to most likely be an enteric bacterium.

Sodeinde and Goguen reported sequence homology among the Pla, OmpT, expressed by Y. pestis and Escherichia coli and the PgtE enzyme expressed by Salmonella enterica, which causes mouse typhoid (25). The DNA sequence identity between the pla and pgtE genes within the coding regions is 69% (25).

PgtE is known to be involved in the host dissemination of S. enterica (26). PgtE can degrade gelatine and activate matrix metalloproteinase 9 (26) to enhance bacterial motility. The deletion of the pgtE gene from S. enterica resulted in a ten-fold reduction in bacterial dissemination within hosts to the liver and the spleen following intraperitoneal infection in BALB/c (26). Although other scientists began to observe that the dissemination of S. enterica within the host involves a constant phagocytosis process by antigen presenting cells (APCs) such as macrophages and dendritic cells (2731), the molecular mechanism through which PgtE promotes bacterial dissemination in hosts has been thought to be associated with its ability to disrupt adjacent tissues too.

However, the results from a 2008 study appeared to challenge this accepted mechanism by reporting that the Pla of Y. pestis interacted with a C-type lectin, DEC-205 (CD205), which is typically expressed on antigen-presenting cells (APCs). By Pla-mediated binding to DEC-205, Y. pestis might be able to hijack alveolar macrophages or lung dendritic cells, acting as Trojan horses to facilitate dissemination from the lungs to the spleen (32). DEC-205 was originally identified as a strong antigen-presenting receptor by Nussenzweig and Steinman’s group (3335). By conjugating with other antigenic proteins, such as the proteins expressed by pancreatic cancers, the hybridized DEC-205 displayed a strong adjuvant effect on the host immune response to pancreatic cancers (36, 37).

Although sequence comparisons have suggested the possibility that Pla in Y. pestis might have derived from PgtE in Salmonella enterica (25), no direct evidence has been reported to support any functional links between PgtE and Pla. Based on the findings published on Journal of Biological Chemistry in 2008 (32), we were using a similar approach to investigate whether the C-type lectin receptor CD205 would also bind to PgtE from S. enterica to facilitate host dissemination and bacterial infection in Y. pestis. The results from this study might help us a further understanding of how Y. pseudotuberculosis that causes mild mesenteric lymphadenitis and self-limited diarrhea has evolved to such a deadly and distinctive pathogen, Y. pestis.

Materials and Methods

Ethics Statement

All animal procedures and human experiments were conducted in strict accordance with the Institutional Animal Care and Use Committees (IACUCs) and Institutional Review Board (IRB) of Tongji Hospital, Tongji Medical College, China. The handling of mice and all experimental procedures were specifically approved for this study by the Medical Ethics Committee of Tongji Hospital and were performed in accordance with institutional guidelines (IRB ID: TJ-A20141220 for animal experiments). All procedures on mice were performed under sodium pentobarbital anesthesia; all efforts were made to minimize animal suffering.

Mice

C57BL/6J mice, aged 6–8 weeks, were purchased from Wuhan University Animal Center, China. Mice were housed in the animal facilities at the Tongji Hospital, in direct accordance with the guidelines drafted by the Animal Care Committees of Tongji Hospital.

Bacterial Strains

Bacterial strains used in this study were listed in Table 1. Y. pseudotuberculosis Y1 is a strain that lacks the virulence plasmid (pYV) and was used as a positive control in the cell invasion assay in previous publications, because this strain appears invading almost all mammalian cells lines (32, 4046).

TABLE 1
www.frontiersin.org

Table 1 Bacteria strains and cell lines used in the study.

Y. pestis 1418 originates from KIM5 (KIM D27), a strain from which the pgm (pigmentation) locus was deleted (45) and it therefore is bio-safety level II strain. In this study, the virulence plasmid (pCD1) and the ail gene were also deleted (32, 41). There are two purposes for construction of this non-virulence Y. pestis. First, one of the important functions of Ail is to mediate Y. pestis attachment to and invasion into the host cells (47, 48). The second reason was for the biosafety issues set by our regulators. Strain Y.p1419 originates from Y. pestis 1418 but features the additional deletion of pPCP1 plasmid. Y. pestis strains Y.p1419 pla+ and Y.p1419 pgtE+ are derivatives of Y. pestis 1419 that carries plasmids pMRK1 and pMRK3 that express the Y. pestis Pla and Salmonella PgtE.

Y. pestis Y.p91001 was isolated from Microtus-related plague focus in China, and is avirulent to humans but can cause plague in rodents belonging to the genus Microtus and laboratory mice (45, 4951). Y. p 9100pPCP1- is Y. pestis 91001, from which the plasmid pPCP1 has been cured. Y. p91001pPCP1-pla+ is Y.p91001-pPCP1- restored with the plasmids pMRK1 encoding Y. pestis Pla. Y. p91001pPCP1-pgtE+is Y.p91001-pPCP1- restored with the plasmids pMRK3 encoding Salmonella PgtE.

E. coli pla+ carries the plasmid pMRK1 that expresses the Pla of Y. pestis. E. coli pgtE+ carries the plasmid pMRK3 that expresses the Salmonella PgtE.

The Y. pestis is cultured at 26°C in Luria-Bertani (LB) for 48 hours with shaking to log phase. The E. coli is cultured at 37°C in Luria-Bertani (LB) overnight with shaking to log phase.

The plasmid pMRK1 was constructed by cloning complete opening reading frame of pla from plasmid pC4006 into pSE380 plasmid (52). The source of Pla sequences for transgene expression is Y. pestis KIM5 pgml (spontaneous non pigmented mutant of Y. pestis KIM) (25).

The source of PgtE sequences for transgene expression was from the genomic DNA of S. enterica SH401 (database accession number AF239770) (53). The plasmid pMRK3 was constructed by cloning the complete reading frame of pgtE from S. enterica SH401 into pSE380 plasmid (53, 54).

Generation of the pla-Knockout of Y. pestis 91001

For generating the pla knockout strain, CRISPR-Cas12a system were used to delete the pla gene in the plasmid pPCP1 of Y. pestis, following the protocol that worked on other Y. pestis strains (55). Briefly, a protospacer adjacent motif (PAM) TTC and a short DNA sequence adjacent to the protospacer site were selected from the coding sequence of the pla gene. Two complementary oligonucleotides (crRNA-pla top and crRNA-pla bottom) containing the protospacer sequence were synthesized, annealed to yield a protospacer cassette with BsaI overhangs at the 5’and 3’ends. Then the protocpacer was cloned into the crRNA expression plasmid pAC-crRNA-Cm to generate the recombinant plasmid pcrRNA-pla-Cm. An 80 nt ssDNA oligonucleotide (pla oligo for lagging) with identity to flanking regions sequence on both sides of the pla gene was synthesized. The ssDNA oligonucleotides and the recombinant plasmid pcrRNA-inv-Cm were co-transformed into Y. pestis cells harboring the plasmid pKD46-cpf1 (Cas12a). The transformants were plated on LB agar supplemented with 100 μg/mL ampicillin and 30 µg/mL chloramphenicol and incubated at 26°C Single colonies were picked up to inoculate LB medium supplemented with appropriate antibiotics at 26°C. PCR was used with appropriate primers to carry out preliminary screen, and sequencing to verify the pla deletion clones. The primers used in this study were listed in Table 2. Finally, the plasmids pcrRNA-pla-Cm and pKD46-cpf1 were cured from the strain by incubating on LB agar plate with supplemented with 7% of sucrose, and by incubating in LB medium at 42°C with shaking overnight, respectively. The plasmids used in this study were listed in Table 3.

Biological Reagents

Human Glu-Plasminogen was purchased from Hematologic Technologies (Essex Junction, VT, USA), and the chromogenic plasmin substrate S-2251 was purchased from Chromogenix (Milano, Italy). Anti-human CD205 antibodies were purchased from Pharmingen (San Diego, CA, USA).

Cell Lines

CHO-m-DEC205 was generated by transfecting CHO cells with the corresponding human C-type lectin cDNA. Transfected cells were selected by G418 (1.5 mg/ml) and screened for the stable surface expression of CD205. CHO-NEO, which expresses the neomycin resistance gene without other exogenous genes, was used as the control cell line (32). Cells were cultured in RPMI supplemented with 10% fetal calf serum (FCS), streptomycin (100 μg/ml), and penicillin (100 units/ml) and incubated at 37°C with 5% CO2.

Isolation of Mouse Alveolar Macrophages

C57BL/6J mice, aged 6–8 weeks, were anesthetized (32). Alveolar macrophages were obtained using the following procedures. After the mice were euthanized, the bronchial tract was opened, the upper bronchia tract was ligated with surgical suture and 1 ml of RPMI medium was injected into the lungs through a syringe. The mouse chest was gently massaged for 3 mins, and then the lavage fluid was collected. The cell number in the lavage fluid was adjusted to 1×105 cell/ml. A glass-slide was plated in the 24-wells plate before seeding the cells. The macrophages were seed into 24-wells plates at the concentration of 1×105 cell/well and placed in RPMI medium with 2% FBS in a CO2 incubator for 2 h. The cell layers were washed three times to remove non-adherent cells.

Cell Invasion Assay

The cell invasion assays were performed as described previously (43, 44). CHO and CHO-m-DEC205 cells were suspended in RPMI 1640 medium supplemented with 2% FCS. Cells were plated in 24-wells plates at a density of 1 × 105 cells/well in 0.5 ml medium. Then, 50 µl of bacterial suspensions were added at a concentration of 1 × 107 colony-forming units (CFU)/ml,5×105CFU in total. Y. pestis was centrifuged at 500 rpm for 5min to initiate the in vitro infection. The cells were incubated with the bacteria at 37°C for 2.5 h with 5% CO2. The cells were washed with phosphate-buffered saline (PBS) three times. To kill any extracellular bacteria, 2 ml RPMI-1640 containing 2% fetal bovine serum (FBS) containing gentamycin, at 100 μg/ml, was added to each well and incubated for 1 hour. The cells in the 24-well plate were washed twice with PBS, and then the cells were lysed with 1 ml 1% Triton X-100. The cell lysates were diluted and plated on LB agar plates. The bacterial colonies recovered from the lysed cells were counted after 2 days to define the level of internalized bacteria in the host cells. All experiments were performed in triplicate, and the data were expressed as the mean ± standard error.

Plasminogen Activation Assay

Plasminogen activation was measured as described in previously published studies (46, 52, 53). Briefly, 8×107 of bacteria were suspended in PBS and combined with 4 μg human Glu-Plasminogen and 0.45 mM S-2251 in 96-well plates, at a final volume of 200 µl, followed by incubation at 37°C. The absorption values at 405 nm were measured at 30-min intervals. The results are presented as the difference between each measurement value and the starting value.

Animal Challenge for Bacterial Dissemination

Y. pestis were cultured at 27°C and suspended in PBS at an OD600 = 1, resulting in the retrieval of 3 ml bacterial suspension (32). C57BL/6J mice, 6–8 weeks of age, 5 mice in each group, were inoculated with 20 µl bacterial suspension, 2*107 CFU in total, via the intranasal route using the following bacteria: Y.p91001, Y.p91001pPCP1-, Y.p91001pPCP1-pla+ and Y.p91001 pPCP1-pgtE+, and another panel of bacteria Y.p91001, Y.p91001pla-, Y.p91001pla-+pla+, Y.p91001pla-+pgtE+. It is should be stated that all the strains of Y. pestis used here were the virulence plasmid (pYV) -cured derivatives of Y. pestis. After 3 days of infection, the liver and spleen were collected and homogenized in 1% Triton X-100 to release the bacteria. The tissue lysate was plated onto LB agar plates supplemented with 50μg/ml ampicillin as shown in our previous publications (41, 45, 46). The dissemination rate was calculated by determining the CFU recovered from the lysed tissue samples.

Animal Challenge for Survival

Y. pestis 91001 were cultured at 27°C, collected by centrifugation, and suspended in PBS at OD600 = 1, resulting in the collection of 3 ml bacterial suspension following centrifugation (45). C57BL/6J mice, aged 6-8 weeks, were infected with 20 µl of the various Yersinia suspensions, 2*107 CFU in total, via the intranasal route. Ten mice in each group were infected by two sets of bacteria, including Y.p91001, Y.p91001 pPCP1-, Y.p91001 pPCP1-pla+ and Y.p91001 pPCP1-pgtE+ strains. The death of the mice was recorded every 12 h for 12 days.

Histopathological Studies

Samples from either the dissemination or survival assays were fixed in 4% neutral buffered formalin. Tissue embedding, sectioning, and staining with hematoxylin and eosin (H&E) were performed by the Servicebio biological laboratory. Stained sections were analyzed under a light microscope.

Statistical Analyses

All statistical analyses were completed using Prism software, version 6 (Graph Pad, San Diego, CA, USA). Significance was assessed using ANOVA test. Survival group comparisons were performed via the log-rank test using Kaplan–Meier analysis. P<0.05 was considered to be the threshold for significance.

Results

PgtE Expressed in Y. pestis Can Activate Plasminogen Into Plasmin

One proposed mechanism for the dissemination of Y. pestis depends on the plasminogen activator Pla, which can degrade fibrous connections in the tissue matrix. We examined whether Y. pestis strains that express PgtE of S. enterica could activate plasminogen to plasmin similar to the action of Pla. Plasmids expressing Pla and PgtE were transformed into the Y. pestis strain 1419 that does not contain the pPCP1 plasmid. We compared the plasminogen activation activity among Y. p1419 pPCP1+, Y.p1419, Y.p1419 pgtE+ and E.coli, E.coli pla+., Y.p1418, which expresses Pla, were used as positive controls (53). Y. p1419 was used as the negative control. As shown in Figure 1, Y.p 1418 showed the highest plasminogen activation activity among the examined strains. Y.p1419 pPCP1+ showed higher plasminogen activation activity than Y.p1419 pgtE+ (53). Consistent with previous studies, this result also indicated that Pla induced higher plasminogen activation activity than PgtE did.

FIGURE 1
www.frontiersin.org

Figure 1 PgtE in recombinant Y. pestis activates plasminogen to plasmin. The plasminogen activation activities of Y.p1419 pPCP1+, Y.p1419, Y.p1419 pgtE+ and E.coli, E.coli pla+ were compared. Y.p1418 was used as a positive control. PBS was used as negative control. The data presented were pooled from three independent experiments.

These data demonstrated that Y. pestis Pla and S. enterica PgtE shared similar functions with regarding to the activation of plasminogen into plasmin, suggesting that Y. pestis Pla might have evolved from S. enterica PgtE.

PgtE-Expressing E. coli and Y. pestis Enhance Phagocytosis by Primary Alveolar Macrophages and Invade CHO-DEC-205

Our previous study demonstrated that Pla in Y. pestis could promote the invasion of alveolar macrophages, mediated by the interaction with the C-type lectin receptor CD205 (32). Therefore, we tested the invasion of alveolar macrophages by two panels of bacteria, including E. coli, E. coli pla+, E. coli pgtE+ and Y.p1418, Y.p1419, Y.p1419 pla+, Y.p1419 pgtE+.

As shown in Figure 2, we found that the both Pla- and PgtE-expressing Y. pestis and E. coli were able to enhance the invasion of bacteria into mouse alveolar macrophages. Previous studies have indicated that mouse alveolar macrophages express a C-type lectin DEC-205, which could be hijacked by Y. pestis via PLA, leading to dissemination within the host (32, 58). It was therefore investigated whether CD205 plays a role in the phagocytosis of recombinant E. coli and Y. pestis pgtE via alveolar macrophages.

FIGURE 2
www.frontiersin.org

Figure 2 PgtE-expressing E. coli and Y. pestis invade alveolar macrophages and invade CHO-m-DEC-205. (A) PgtE-expressing E. coli were examined for their ability to enter alveolar macrophages. The bacteria used were E. coli, E. coli pla+ and E. coli pgtE+. (B) PgtE-expressing Y. pestis were examined for their ability to enter alveolar macrophages. The bacteria used were Y.p1418, Y.p1419, Y.p1419 pla+, Y.p1419 pgtE+.The number of phagocytized bacteria was determined by evaluating the CFUs on the plates after two days. The data presented were collective from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. (C) PgtE-expressing E. coli invade the CHO cell line expressing CD205. Epithelial CHO cells expressing or not expressing CD205 (CHO and CD205, respectively) were infected with PgtE- and Pla-expressing E. coli. Y. pseudotuberculosis (Y1); E. coli, E. coli pla+, and E. coli pgtE+ were examined for their abilities to invade CHO/CHO-m-DEC-205 cells during a gentamicin protection assay, in presence or absence of anti-DEC-205 (5 μg/ml). The numbers of phagocytosed bacteria were determined by counting the bacterial CFUs on the plates the next day. The data presented were pooled from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. (D) PgtE-expressing Y. pestis invades the CHO cell line expressing CD205. Epithelial CHO cells expressing or not expressing CD205 (CHO and CD205, respectively) were infected with PgtE- and Pla-expressing Y. pestis. Y. pseudotuberculosis (Y1), Y.p1419, Y.p1419 pla+ and Y.p1419 pgtE+ were examined for their abilities to invade CHO/CHO-m-DEC-205 cells during a gentamicin protection assay, in presence or absence of anti-DEC-205 (5 μg/ml). The numbers of phagocytosed bacteria were determined by counting the bacterial CFUs on the plates after two days. The data presented were pooled from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.

(32), We further explored whether this interaction was mediated by the binding between PgtE and CD205 on mouse alveolar macrophages. The results shown in Figures 2C, D demonstrated that the CHO-mDEC-205 cells were able to phagocytize PgtE-expressing E. coli and Y. pestis. E. coli pla+ was used as a control for its ability to interact with DEC-205 in Figure 2C (32). This CD205-PgtE interaction was inhibited by anti-CD205 antibody (Figures 2C, D). Y. pseudotuberculosis was used as another control for its invasion of almost all epithelial cells (32, 38, 45, 46).

Based on the above evidence, we conclude that CD205 serves as a receptor for PgtE and contributes to the phagocytosis of PgtE-expressing E. coli and Y. pestis, indicating that PgtE and Pla share a similar ability to binding to the C-type lectin receptor CD205. The inhibition of the interaction by adding the anti-CD205 antibody supports that the binding is specific, and that CD205 functions as a receptor in the interaction between CD205 and pgtE-expressing E. coli and Y. pestis.”

PgtE Expressed in Y. pestis Confers the Ability to Promote Host Dissemination

We showed previously that Pla in Y. pestis could bind to CD205 to facilitate the dissemination of Y. pestis (32). Therefore, we hypothesized that the dissemination of Y. pestis to the spleen and liver would also be facilitated by the PgtE-CD205 interaction. To mimic evolution, we chose a wild-type and Y. pestis strain 91001 that contains the pigmentation locus, pgm, and the plasmids pCD1 and pPCP1 (Figure 3) (49).

FIGURE 3
www.frontiersin.org

Figure 3 PgtE expressed in Y. pestis enhances the ability to promote host dissemination. Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p91001 pPCP1-pgtE+ were used to challenge mice via the intranasal route. After 72 hours of infection, the liver and spleen were collected and homogenized. The bacterial loads were quantified by counting the bacteria colonies on the plates after two days. (The data shown were obtained from three independent experiments. *P < 0.05, **P < 0.01.

C57BL/6J mice were inoculated via the intranasal route with Y. pestis Y.p91001, its isogenic strain that lacks Pla (Y.p91001pPCP1-), the pPCP1-strain complemented with the coding sequence for Pla (Y.p91001pPCP1-pla+), and the pPCP1-strain complemented with the coding sequence for PgtE (Y.p 91001pPCP1-pgtE+).

The dissemination rates of bacteria into the different organs were calculated by counting the CFUs on the plates. Figure 3 shows that the CFU numbers of 91001pPCP1 were lower than the other strains that were isolated from the liver and spleen. Furthermore, both Y.p91001pPCP1-pla+ and Y.p91001pPCP1-pgtE+ were able to disseminate to the liver and spleen. In short, the results suggested that PgtE conferred the ability to promote host dissemination of Y. pestis.

The Expression of PgtE in Y. pestis Enhances the Fatality Rate in Mice

CD205 appeared to participate in the in vitro interaction of PgtE-expressing E. coli or Y. pestis with APCs; however, whether this interaction also occurs in vivo remained to be elucidated. C57BL/6J mice were inoculated via the intranasal route with Y. pestis Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p 91001 pPCP1-pgtE+. The survival of the mice infected with these various Y. pestis strains was monitored. In addition, we knocked out pla in the plasmid of pPCP1 (Y.p 91001pPCP1) and introduced pMRK1 (the plasmid vector pSE380 carrying pla) and pMRK3 (the plasmid vector pSE380 carrying pgtE).

As shown in Figure 4A, we found that mice infected with wild-type Y. pestis 91001 succumbed to the infection. Curing of the pPCP1 from Y. pestis 91001 reduced the virulence, which is consistent with the finding from Lathem et al., who reported that the inhibition of Pla expression prolonged the survival of animals (20). We next restored the expression of Pla or PgtE using specific plasmids, which rescued the virulence of Y. pestis. However, compared with the Pla+ bacteria, their PgtE+ isogenic variants showed significantly lower virulence.

FIGURE 4
www.frontiersin.org

Figure 4 Mice infected intranasally with PgtE-expressing Y. pestis are more susceptible to death compared with pPCP1 plasmid cured and pla-deleted Y. pestis. (A) Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p91001 pPCP1-pgtE+ were used to challenge mice via the intranasal route. The mice were monitored for 12 days, and the log-rank test was performed. (B) Y.p91001, Y.p91001pla-, Y.p91001pla-+pla+, Y.p91001pla-+pgtE+ were used to challenge mice via the intranasal route. The data shown were obtained from three independent experiments.

In Figure 4B, Y.p91001, Y.p91001pla-, Y.p91001pla-+pla+, Y.p91001pla-+pgtE+ were administered to mice by intranasal challenge. We found that the absence of pla attenuated in a mouse model of pneumonic plague infected by Y. pestis 91001. Restoring Pla expression in Y.p91001pla- can almost restore the virulence to Pla(-) mutant. Overexpression of PgtE from plasmid alone can also increase the mortality rate of mice. We have shown that PgtE played a critical pathogenic role in mice succumbed to respiratory infection.

We concluded that PgtE-promoted bacterial dissemination and virulence in host may be due to in part the ability of PgtE to interact with CD205.

PgtE-Expressing Y. pestis Increases Lung Tissue Inflammation

After determining the survival rate of mice, we explored whether the interaction between CD205 and Pla promotes the virulence of Y. pestis. We examined pathological changes in sections of infected lung histologically, using H&E staining. C57BL/6J mice were infected via intranasal inoculation of Y. pestis Y.p91001, Y.p91001pPCP1-, Y.p91001pPCP1-pla+ and Y.p91001pPCP1-pgtE+ strains. Mice inoculated with PBS were used as control. 48 hours after infection, the lung pathological changes were examined in the mice. As shown in Figure 5A, an influx of inflammatory cells could be detected in all lung tissue sections from infected mice. Tissue destruction and hemorrhage were more severe in 91001 wild-type- and Y.p91001pPCP1 pla+or pgtE+-infected mice than in 91001pPCP1 infected mice. However, the increasing tissue damages were most likely resulted of the increasing presences of bacteria.

FIGURE 5
www.frontiersin.org

Figure 5 The expression of PgtE in Y. pestis was able to enhance the inflammatory lesions in the lungs from C57BL/6 mice. (A)Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p91001 pPCP1-pgtE+ were used to challenge mice via the intranasal route. Lung damage was examined by hematoxylin and eosin (H & E) staining of formalin-fixed sections 48 hours after infection. C57BL/6 mice were inoculated with PBS (mock), Y. pestis Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p 91001pPCP1-pgtE+ strains Representative images of inflammatory lesions are shown. (B) The bacteria amount in the lung tissues of the mice infected by Y.p91001, Y.p91001pPCP1-, Y.p91001 pPCP1-pla+ and Y.p91001 pPCP1-pgtE+ were examined 8 hours after infection. **P < 0.01, ***P < 0.001.

The amount of bacteria in the lung tissues was determined in parallel with the data from the histological examination. Y.p91001pPCP1-pla+ is Y.p91001-pPCP1- restored with the plasmids pMRK1 encoding Y. pestis Pla, and Y.p91001pPCP1-pgtE+ is Y.p91001-pPCP1- restored with the plasmid pMRK3 encoding Salmonella pgtE. As shown in Figure 5B, mice infected with Y.p91001pPCP1-pla+ and Y.p91001pPCP1-pgtE+ showed exhibited a larger amount of bacteria in the lung tissues than the mice infected by 91001pPCP1−, especially the mice infected with Y.p91001pPCP1-pla+. This is consistent with the lung histological results.

Consistent with the results of the survival assay described above, we showed that the plasminogen-activating activity of Pla is essential to Y. pestis virulence during the injury of lung tissue.

Discussion

In this study, we identified CD205 as a cellular receptor for PgtE, enhancing the host dissemination and infection abilities of Y. pestis. PgtE-expressing Y. pestis may utilize a similar mechanism as that demonstrated for the Pla-DEC205 interaction (32). Our data from this study indicated that PgtE and Pla shared functional similarity and were both able to bind with the C-type lectin receptor CD205. The expression of Pla and PgtE in pPCP1−/− Y. pestis increased the mortality rate in a pneumonic plague mice model. These findings provided evidence from a functional perspective that Pla might have derived from PgtE.

The pPCP1 plasmid was acquired by an ancestral Y. pestis strain during the divergence from Y. pseudotuberculosis into modern Y. pestis (16). The key factor that promotes Y. pestis pathogenesis is plasminogen activator (Pla), which is encoded by the pPCP1 plasmid. In detail, biovar Caucasica (0.PE2) lack pla, pla in all the stains of the biovars Altaica (0.PE4), Qinghaiensis (0.PE4ab), Xilingolensis (0.PE4cd), Talassica (0.PE4), Hissarica (0.PE4), and Ulegeica (0.PE5) is the I259 phenotype. Bronze-Age (0. PRE1, 0. PRE2) (59), and Neolithic-lineage strain (6) were also express the ancestral pla allele (5). The most important event in the virulence optimization was the single substitution I259T occurred on the ancestral Y. pestis Microtus and Angola species; this increased the fibrinolytic activities of the Pla (16). In the ancestral Y. pestis lineages Microtus and Angola, the residue 259 in Pla is isoleucine. A single substitution I259T occurs in the ancestral lineages, in the modern lineages KIM and CO92 of Y. pestis, the position 259 is threonine (16). Cui et al. articulated that this modification of PLA may be the ‘big bang’ event during the evolution of Y. pestis (60, 61).

The notion, in which microbial pathogens are able to utilize the C-type lectins and the antigen presenting cells (APCs) as tools to achieve host dissemination, has started for two decades. The most established example of this process is the infection of the human immunodeficiency virus (HIV), which is mediated by the binding of HIV gp120 protein with DC-SIGN (CD209), to facilitate the infection of CD4+ T-cells (6264).

In a series of our previous studies, we demonstrated that C-type lectin receptors, such as DEC-205 (CD205), Langerin (CD207), and DC-SIGN, on APCs, can bind with several Gram-negative bacteria, including Y. pestis, Y. pseudotuberculosis, and S. enterica serovar Typhimurium, through the core bacterial LPS, which is a key component of the outer membrane of Gram-negative bacteria, to promote bacterial dissemination (3841, 45, 46, 48, 6571). Our very recent report indicated that the dissemination of parasites might also follow a similar mechanism (68). These studies, particularly the 2008 report published in the Journal of Biological Chemistry (32), formed the foundation for this current study.

In the current study, two sets of Y. pestis with distinctively different virulence were used. One set of Y. pestis included Y.p1418, Y.p1419, Y.p1419 pla+ and Y.p1419 pgtE+. The virulence of this set of bacteria is attenuated due to deficient pigmentation activity. The other set is the strain Y. pestis 91001 is, which a strain that was isolated from Microtus brandti in China, with the phenotype F1+/LcrV+/Pst+/Pgm+ (51). In short, in order to address biosafety concerns regarding different protocols, we performed the in vivo assay using the Y. pestis 91001 strains in a biosafety level III lab through collaboration with other co-authors.

Unlike the 2008 study (32), in which none of virulent strains was used, we examined whether the acquisition of PgtE would be sufficient to cause pneumonic plague following intranasal inoculation in the pneumonic plague mouse model. We infected the mice with a panel of virulent 91001 strains to examine the PgtE/mDEC-205 interaction-mediated virulence in vivo. Our experiments showed PgtE was in part able to rescue the competence of Y. pestis. This finding was consistent with the findings of a previous study, suggesting that the ancestral isolate Pestoides F, which does not carry pPCP1, was not speculated to cause primary pneumonic plague, whereas the expression of Pla in Pestoides F empowered the bacteria to cause pneumonic plague in a mouse model (16).

Our results showed that the expression of PgtE in Y. pestis with deleted pPCP1 was partially able to restore several functions, including plasminogen activation activity, phagocytosis by alveolar macrophages, the invasion of C-type Lectin mDEC-205-expressing cell lines, and systemic dissemination in the host. These characteristics are similar to those ascribed for Pla in previous studies from our lab and other researchers (20, 32). The ability of PgtE to restore partially the infective abilities of Y. pestis revealed the functional similarity between PgtE from S. enterica and Pla from Y. pestis and provided evidence to support the hypothesis that Pla in Y. pestis might have derived from PgtE from S. enterica during evolution.

CD209 and CD205 are two members of the C-type lectin receptor family, but they exhibit different characteristics. CD209 can bind with the sugar ligands from different bacteria (Gram-negative bacteria) (3841, 45, 46, 6570), viruses (human immunodeficiency virus) (6264), and parasites (Toxoplasma gondii) (68). Thus, CD209 is a relatively unspecific receptor. In fact, the authors claim that CD209 might be responsible for almost all the so-called “non-specific binding” mediated by APCs. In contrast, CD205 can only bind with certain protein ligands, for example, the Pla of Yersinia pestis (32), and the pgtE of Salmonella enterica used in the current study. Thus, CD205 is a specific C-type lectin receptor.

As was summarized in 2006, “From an evolutionary point of view, the interaction of bacterial core LOS/LPS and the innate immune receptor, DC-SIGN, may represent a primitive interaction between microbial pathogens and the professional phagocytic host cells” (67). Moreover, in 2019, the following was stated: “We therefore propose that the loss of O-antigen represents a critical step in the evolution of Y. pseudotuberculosis into Y. pestis in terms of hijacking APCs, promoting bacterial dissemination and causing the plague” (45). Historically, CD209 has played a profound role in the evolution of pathogens, and CD205 is more specific in binding with protein ligands.

In summary, the original goal of this study was to understand of how Y. pseudotuberculosis, an enteric bacterial pathogen that causes only mild enteric infection, has evolved to such a deadly and distinctive pathogen, Y. pestis. The result provided in the study showed the PgtE from S. enterica can enhance the invasive abilities of Y. pestis through the binding of the C-type lectin receptor CD205. The CD205-PgtE interaction, similar to the CD205-Pla interaction (32), may allow the infected APCs to function as Trojan Horses, to promote dissemination within mammalian hosts and infection of Y. pestis. These results provide additional evidence to suggest that Pla in Y. pestis might have originated from PgtE in S. enterica. Finally, this study was initially focused on Y. pestis, which may however uncover for the first time one of molecular mechanisms of how S. enterica is able to be disseminated in the mammalian hosts.

TABLE 2
www.frontiersin.org

Table 2 Primers and oligonucleotides used in this study.

TABLE 3
www.frontiersin.org

Table 3 Plasmids employed in this study.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.

Ethics Statement

The animal study was reviewed and approved by Animal Care Committees of Tongji Hospital.

Author Contributions

QL and CLY and FZ performed the experiments, analyzed the data, and wrote the manuscript. WJL, SZZ, YL, CGP, YMZ, L-YJ, KY, YXH, HHC,SZ, H-HD, OAN, JMT, and AAA assisted with the experiments. A-YL and Z-YS provided critical reagents and advice. WL, M-YY, BK, XXH, JDK, MS, APA, XFG, YPH, R-FY, XDXM, and YZW, HXC, BC provided critical reagents and advice. TC, YCS, and JPY supervised the project, designed the experiments, and modified the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by grants from the National Natural Science Foundation of China [NSFC 81271780 and 81471915] and two local grants from Tongji Hospital, Tongji Medical College (T.C.). CP was supported by grants from the National Research Foundation of Korea [NRF-2019R1F1A1041700]. APA was supported the Ministry of Science and Higher Education of the Russian Federation [agreement number 075-15-2019-1671]. HXC was supported by Shenzhen Basic Research Project (Natural Science Foundation) Basic Research Project (No. JCYJ20190809103805589, No. JCYJ20210324112213036).

Conflict of Interest

CP was employed by Genuv Inc.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We are grateful to Dr. Benita Westerlund-Wiklund (University of Helsinki) for the donation of Pla and PgtE-expressing plasmids. Finally, we are especially grateful for the support of the Tongji Hospital of Huazhong University of Science and Technology for the project being continued.

References

1. Perry RD, Fetherston JD. Yersinia Pestis–Etiologic Agent of Plague. Clin Microbiol Rev (1997) 10:35–66. doi: 10.1128/CMR.10.1.35

CrossRef Full Text | Google Scholar

2. Prentice Michael B, Tom G, Cooper A. Was the Black Death Caused by Yersinia Pestis? Lancet Infect Dis (2004) 4:72. doi: 10.1016/s1473-3099(04)00923-5

CrossRef Full Text | Google Scholar

3. Bos Kirsten I, Schuenemann Verena J, Golding GB, Burbano Hernán A, Waglechner N, Coombes Brian K, et al. A Draft Genome of Yersinia Pestis From Victims of the Black Death. Nature (2011) 478:506–10. doi: 10.1038/nature10549

CrossRef Full Text | Google Scholar

4. Spyrou MA, Tukhbatova RI, Feldman M, Drath J, Kacki S, Beltran de Heredia J, et al. Historical Y. Pestis Genomes Reveal the European Black Death as the Source of Ancient and Modern Plague Pandemics. Cell Host Microbe (2016) 19:874–81. doi: 10.1016/j.chom.2016.05.012

CrossRef Full Text | Google Scholar

5. Sebbane F, Uversky VN, Anisimov AP. Yersinia Pestis Plasminogen Activator. Biomolecules (2020) 10:1554. doi: 10.3390/biom10111554

CrossRef Full Text | Google Scholar

6. Rascovan N, Sjogren KG, Kristiansen K, Nielsen R, Willerslev E, Desnues C, et al. Emergence and Spread of Basal Lineages of Yersinia Pestis During the Neolithic Decline. Cell (2019) 176:295–305.e10. doi: 10.1016/j.cell.2018.11.005

CrossRef Full Text | Google Scholar

7. Roffey R, Tegnell A, Elgh F. Biological Warfare in a Historical Perspective. Clin Microbiol Infect (2002) 8:450–4. doi: 10.1046/j.1469-0691.2002.00501.x

CrossRef Full Text | Google Scholar

8. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia Pestis, the Cause of Plague, Is a Recently Emerged Clone of Yersinia Pseudotuberculosis. Proc Natl Acad Sci USA (1999) 96:14043–8. doi: 10.1073/pnas.96.24.14043

CrossRef Full Text | Google Scholar

9. Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, Kusecek B, et al. Microevolution and History of the Plague Bacillus, Yersinia Pestis. Proc Natl Acad Sci USA (2004) 101:17837–42. doi: 10.1073/pnas.0408026101

CrossRef Full Text | Google Scholar

10. Chain PSG, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, et al. Insights Into the Evolution of Yersinia Pestis Through Whole-Genome Comparison With Yersinia Pseudotuberculosis. Proc Natl Acad Sci USA (2004) 101:13826–31. doi: 10.1073/pnas.0404012101

CrossRef Full Text | Google Scholar

11. Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, Wagner DM, et al. Yersinia Pestis Genome Sequencing Identifies Patterns of Global Phylogenetic Diversity. Nat Genet (2010) 42:1140–3. doi: 10.1038/ng.705

CrossRef Full Text | Google Scholar

12. Weber J, Finlayson NB, Mark JB. Mesenteric Lymphadenitis and Terminal Ileitis Due to Yersinia Pseudotuberculosis. N Engl J Med (1970) 283:172–4. doi: 10.1056/NEJM197007232830404

CrossRef Full Text | Google Scholar

13. Samoilova SV, Samoilova LV, Yezhov IN, Drozdov IG, Anisimov AP. Virulence of Ppst+ and Ppst- Strains of Yersinia Pestis for Guinea-Pigs. J Med Microbiol (1996) 45:440–4. doi: 10.1099/00222615-45-6-440

CrossRef Full Text | Google Scholar

14. Welkos SL, Friedlander AM, Davis KJ. Studies on the Role of Plasminogen Activator in Systemic Infection by Virulent Yersinia Pestis Strain C092. Microb Pathog (1997) 23:211–23. doi: 10.1006/mpat.1997.0154

CrossRef Full Text | Google Scholar

15. Anisimov AP, Lindler LE, Pier GB. Intraspecific Diversity of Yersinia Pestis. Clin Microbiol Rev (2004) 17:434–64. doi: 10.1128/CMR.17.2.434-464.2004

CrossRef Full Text | Google Scholar

16. Zimbler DL, Schroeder JA, Eddy JL, Lathem WW. Early Emergence of Yersinia Pestis as a Severe Respiratory Pathogen. Nat Commun (2015) 6:7487. doi: 10.1038/ncomms8487

CrossRef Full Text | Google Scholar

17. Chen S, Thompson KM, Francis MS. Environmental Regulation of Yersinia Pathophysiology. Front Cell Infect Microbiol (2016) 6:25. doi: 10.3389/fcimb.2016.00025

CrossRef Full Text | Google Scholar

18. Brubaker RR, Beesley ED, Surgalla MJ. Pasteurella Pestis: Role of Pesticin I and Iron in Experimental Plague. Science (1965) 149:422–4. doi: 10.1126/science.149.3682.422

CrossRef Full Text | Google Scholar

19. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A Surface Protease and the Invasive Character of Plague. Science (1992) 258:1004–7. doi: 10.1126/science.1439793

CrossRef Full Text | Google Scholar

20. Lathem WW, Price PA, Miller VL, Goldman WE. A Plasminogen-Activating Protease Specifically Controls the Development of Primary Pneumonic Plague. Science (2007) 315:509–13. doi: 10.1126/science.1137195

CrossRef Full Text | Google Scholar

21. van Lier CJ, Sha J, Kirtley ML, Cao A, Tiner BL, Erova TE, et al. Deletion of Braun Lipoprotein and Plasminogen-Activating Protease-Encoding Genes Attenuates Yersinia Pestis in Mouse Models of Bubonic and Pneumonic Plague. Infect Immun (2014) 82:2485–503. doi: 10.1128/IAI.01595-13

CrossRef Full Text | Google Scholar

22. Korhonen TK. Fibrinolytic and Procoagulant Activities of Yersinia Pestis and Salmonella Enterica. J Thromb Haemost (2015) 13 Suppl 1:S115–20. doi: 10.1111/jth.12932

CrossRef Full Text | Google Scholar

23. Eddy JL, Schroeder JA, Zimbler DL, Bellows LE, Lathem WW. Impact of the Pla Protease Substrate Alpha2-Antiplasmin on the Progression of Primary Pneumonic Plague. Infect Immun (2015) 83:4837–47. doi: 10.1128/IAI.01086-15

CrossRef Full Text | Google Scholar

24. Guinet F, Ave P, Filali S, Huon C, Savin C, Huerre M, et al. Dissociation of Tissue Destruction and Bacterial Expansion During Bubonic Plague. PloS Pathog (2015) 11:e1005222. doi: 10.1371/journal.ppat.1005222

CrossRef Full Text | Google Scholar

25. Sodeinde OA, Goguen JD. Nucleotide Sequence of the Plasminogen Activator Gene of Yersinia Pestis: Relationship to ompT of Escherichia Coli and Gene E of Salmonella Typhimurium. Infect Immun (1989) 57:1517–23. doi: 10.1128/iai.57.5.1517-1523.1989

CrossRef Full Text | Google Scholar

26. Ramu P, Lobo AL, Kukkonen M, Bjur E, Suomalainen M, Raukola H, et al. Activation of Pro-Matrix Metalloproteinase-9 and Degradation of Gelatin by the Surface Protease PgtE of Salmonella Enterica Serovar Typhimurium. Int J Med Microbiol (2008) 298:263–78. doi: 10.1016/j.ijmm.2007.06.004

CrossRef Full Text | Google Scholar

27. Lähteenmäki K, Kyllönen P, Partanen L, Korhonen TK. Antiprotease Inactivation by Salmonella Enterica Released From Infected Macrophages. Cell Microbiol (2004) 7:529–38. doi: 10.1111/j.1462-5822.2004.00483.x

CrossRef Full Text | Google Scholar

28. Sheppard M, Webb C, Heath F, Mallows V, Emilianus R, Maskell D, et al. Dynamics of Bacterial Growth and Distribution Within the Liver During Salmonella Infection. Cell Microbiol (2003) 5:593–600. doi: 10.1046/j.1462-5822.2003.00296.x

CrossRef Full Text | Google Scholar

29. Mastroeni P, Sheppard M. Salmonella Infections in the Mouse Model: Host Resistance Factors and In Vivo Dynamics of Bacterial Spread and Distribution in the Tissues. Microbes Infect (2004) 6:398–405. doi: 10.1016/j.micinf.2003.12.009

CrossRef Full Text | Google Scholar

30. Hueffer K, Galan JE. Salmonella-Induced Macrophage Death: Multiple Mechanisms, Different Outcomes. Cell Microbiol (2004) 6:1019–25. doi: 10.1111/j.1462-5822.2004.00451.x

CrossRef Full Text | Google Scholar

31. Swart AL, Hensel M. Interactions of Salmonella Enterica With Dendritic Cells. Virulence (2014) 3:660–7. doi: 10.4161/viru.22761

CrossRef Full Text | Google Scholar

32. Zhang SS, Park CG, Zhang P, Bartra SS, Plano GV, Klena JD, et al. Plasminogen Activator Pla of Yersinia Pestis Utilizes Murine DEC-205 (CD205) as a Receptor to Promote Dissemination. J Biol Chem (2008) 283:31511–21. doi: 10.1074/jbc.M804646200

CrossRef Full Text | Google Scholar

33. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, et al. The Receptor DEC-205 Expressed by Dendritic Cells and Thymic Epithelial Cells is Involved in Antigen Processing. Nature (1995) 375:151–5. doi: 10.1038/375151a0

CrossRef Full Text | Google Scholar

34. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, et al. The Dendritic Cell Receptor for Endocytosis, DEC-205, can Recycle and Enhance Antigen Presentation via Major Histocompatibility Complex Class II-Positive Lysosomal Compartments. J Cell Biol (2000) 151:673–84. doi: 10.1083/jcb.151.3.673

CrossRef Full Text | Google Scholar

35. Bozzacco L, Trumpfheller C, Siegal FP, Mehandru S, Markowitz M, Carrington M, et al. DEC-205 Receptor on Dendritic Cells Mediates Presentation of HIV Gag Protein to CD8+ T Cells in a Spectrum of Human MHC I Haplotypes. Proc Natl Acad Sci USA (2007) 104:1289–94. doi: 10.1073/pnas.0610383104

CrossRef Full Text | Google Scholar

36. Wang B, Kuroiwa JMY, He L-Z, Charalambous A, Keler T, Steinman RM. The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System When Targeted to the DEC-205/CD205 Receptor on Dendritic Cells. Ann N Y Acad Sci (2009) 1174:6–17. doi: 10.1111/j.1749-6632.2009.04933.x

CrossRef Full Text | Google Scholar

37. Petzold C, Riewaldt J, Koenig T, Schallenberg S, Kretschmer K. Dendritic Cell-Targeted Pancreatic β-Cell Antigen Leads to Conversion of Self-Reactive Cd4+T Cells Into Regulatory T Cells and Promotes Immunotolerance in NOD Mice. Rev Diabetes Stud (2010) 7:47–61. doi: 10.1900/rds.2010.7.47

CrossRef Full Text | Google Scholar

38. Zhang P, Skurnik M, Zhang SS, Schwartz O, Kalyanasundaram R, Bulgheresi S, et al. Human Dendritic Cell-Specific Intercellular Adhesion Molecule-Grabbing Nonintegrin (CD209) Is a Receptor for Yersinia Pestis That Promotes Phagocytosis by Dendritic Cells. Infect Immun (2008) 76:2070–9. doi: 10.1128/IAI.01246-07

CrossRef Full Text | Google Scholar

39. Wu B-c, Njiri AO, Tembo MJ, He Y-x, Zhang Y-m, Xue Y, et al. Loss of the Virulence Plasmid by Shigella Sonnei Promotes its Interactions With CD207 and CD209 Receptors. J Med Microbiol (2021) 70:001297. doi: 10.1099/jmm.0.001297

CrossRef Full Text | Google Scholar

40. Yang K, Park CG, Cheong C, Bulgheresi S, Zhang S, Zhang P, et al. Host Langerin (CD207) Is a Receptor for Yersinia Pestis Phagocytosis and Promotes Dissemination. Immunol Cell Biol (2015) 93:815–24. doi: 10.1038/icb.2015.46

CrossRef Full Text | Google Scholar

41. He Y-X, Ye C-L, Zhang P, Li Q, Park Gyu C, Yang K, et al. Yersinia Pseudotuberculosis Exploits CD209 Receptors for Promoting Host Dissemination and Infection. Infect Immun (2019) 87:e00654-18. doi: 10.1128/IAI.00654-18

CrossRef Full Text | Google Scholar

42. Chen T, Belland RJ, Wilson J, Swanson J. Adherence of Pilus- Opa+ Gonococci to Epithelial Cells In Vitro Involves Heparan Sulfate. J Exp Med (1995) 182:511–7. doi: 10.1084/jem.182.2.511

CrossRef Full Text | Google Scholar

43. Chen T, Grunert F, Medina-Marino A, Gotschlich EC. Several Carcinoembryonic Antigens (CD66) Serve as Receptors for Gonococcal Opacity Proteins. J Exp Med (1997) 185:1557–64. doi: 10.1084/jem.185.9.1557

CrossRef Full Text | Google Scholar

44. Chen T, Bolland S, Cheni I, Parkeri J, Pantelic M, Grunert F, et al. The CGM1a (CEACAM3/CD66d)-Mediated Phagocytic Pathway of Neisseria Gonorrhoeae Expressing Opacity Proteins Is Also the Pathway to Cell Death. J Biol Chem (2001) 276:17413–9. doi: 10.1074/jbc.M010609200

CrossRef Full Text | Google Scholar

45. Yang K, He Y, Park Gyu C, Kang Young S, Zhang P, Han Y, et al. Yersinia Pestis Interacts With SIGNR1 (CD209b) for Promoting Host Dissemination and Infection. Front Immunol (2019) 10:96. doi: 10.3389/fimmu.2019.00096

CrossRef Full Text | Google Scholar

46. Ye C-l, Li Q, Li X, Park Gyu C, He Y-x, Zhang Y, et al. Salmonella Enterica Serovar Typhimurium Interacts With CD209 Receptors to Promote Host Dissemination and Infection. Infect Immun (2019) 87:e00100-19. doi: 10.1128/IAI.00100-19

CrossRef Full Text | Google Scholar

47. Miller VL, Falkow S. Evidence for Two Genetic Loci in Yersinia Enterocolitica That can Promote Invasion of Epithelial Cells. Infect Immun (1988) 56:1242–8. doi: 10.1128/IAI.56.5.1242-1248.1988

CrossRef Full Text | Google Scholar

48. Zhang Y, Ying X, He Y, Jiang L, Zhang S, Bartra SS, et al. Invasiveness of the Yersinia Pestis Ail Protein Contributes to Host Dissemination in Pneumonic and Oral Plague. Microb Pathog (2020) 141:103993. doi: 10.1016/j.micpath.2020.103993

CrossRef Full Text | Google Scholar

49. Zhou D, Tong Z, Song Y, Han Y, Pei D, Pang X, et al. Genetics of Metabolic Variations Between Yersinia Pestis Biovars and the Proposal of a New Biovar, Microtus. J Bacteriol (2004) 186:5147–52. doi: 10.1128/JB.186.15.5147-5152.2004

CrossRef Full Text | Google Scholar

50. Song Y, Tong Z, Wang J, Wang L, Guo Z, Han Y, et al. Complete Genome Sequence of Yersinia Pestis Strain 91001, an Isolate Avirulent to Humans. DNA Res (2004) 11:179–97. doi: 10.1093/dnares/11.3.179

CrossRef Full Text | Google Scholar

51. Zhou L, Ying W, Han Y, Chen M, Yan Y, Li L, et al. A Proteome Reference Map and Virulence Factors Analysis of Yersinia Pestis 91001. J Proteomics (2012) 75:894–907. doi: 10.1016/j.jprot.2011.10.004

CrossRef Full Text | Google Scholar

52. Kukkonen M, Lähteenmäki K, Suomalainen M, Kalkkinen N, Emödy L, Lång H, et al. Protein Regions Important for Plasminogen Activation and Inactivation of Alpha(2)-Antiplasmin in the Surface Protease Pla of Yersinia Pestis. Mol Microbiol (2001) 40:1097–111. doi: 10.1046/j.1365-2958.2001.02451.x

CrossRef Full Text | Google Scholar

53. Kukkonen M, Suomalainen M, Kyllönen P, Lähteenmäki K, Lång H, Virkola R, et al. Lack of O-Antigen is Essential for Plasminogen Activation by Yersinia Pestis and Salmonella Enterica. Mol Microbiol (2003) 51:215–25. doi: 10.1046/j.1365-2958.2003.03817.x

CrossRef Full Text | Google Scholar

54. Guina T, Yi EC, Wang H, Hackett M, Miller SI. A PhoP-Regulated Outer Membrane Protease of Salmonella Enterica Serovar Typhimurium Promotes Resistance to Alpha-Helical Antimicrobial Peptides. J Bacteriol (2000) 182:4077–86. doi: 10.1128/JB.182.14.4077-4086.2000

CrossRef Full Text | Google Scholar

55. Yan M-Y, Yan H-Q, Ren G-X, Zhao J-P, Guo X-P, Sun Y-C. CRISPR-Cas12a-Assisted Recombineering in Bacteria. Appl Environ Microbiol (2017) 83:e00947-17. doi: 10.1128/AEM.00947-17

CrossRef Full Text | Google Scholar

56. Datsenko KA, BL W. One-Step Inactivation of Chromosomal Genes in Escherichia Coli K-12 Using PCR Products. Proc Natl Acad Sci USA (2000) 97:6640–5. doi: 10.1073/pnas.120163297

CrossRef Full Text | Google Scholar

57. Kukkonen M, Korhonen TK. The Omptin Family of Enterobacterial Surface Proteases/Adhesins: From Housekeeping in Escherichia Coli to Systemic Spread of Yersinia Pestis. Int J Med Microbiol (2004) 294:7–14. doi: 10.1016/j.ijmm.2004.01.003

CrossRef Full Text | Google Scholar

58. Diane O, Harton M, Henao-Tamayo M, Montoya R, Orme IM, et al. Enhanced Macrophage Activity in Granulomatous Lesions of Immune Mice Challenged With Mycobacterium Tuberculosis. J Immunol (2006) 176:4931–9. doi: 10.4049/jimmunol.176.8.4931

CrossRef Full Text | Google Scholar

59. Spyrou MA, Tukhbatova RI, Wang CC, Valtuena AA, Lankapalli AK, Kondrashin VV, et al. Analysis of 3800-Year-Old Yersinia pestis Genomes Suggests Bronze Age Origin for Bubonic Plague. Nat Commun (2018) 9(1):2234.

Google Scholar

60. Cui Y, Yu C, Yan Y, Li D, Li Y, Jombart T, et al. Historical Variations in Mutation Rate in an Epidemic Pathogen, Yersinia Pestis. Proc Natl Acad Sci USA (2012) 110:577–82. doi: 10.1073/pnas.1205750110

CrossRef Full Text | Google Scholar

61. Cui Y, Song Y. Genome and Evolution of Yersinia Pestis. Adv Exp Med Biol (2016) 918:171–92. doi: 10.1007/978-94-024-0890-4_6

CrossRef Full Text | Google Scholar

62. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a Dendritic Cell-Specific HIV-1-Binding Protein That Enhances Trans-Infection of T Cells. Cell (2000) 100:587–97. doi: 10.1016/s0092-8674(00)80694-7

CrossRef Full Text | Google Scholar

63. Engering A, Van Vliet SJ, Geijtenbeek TB, Van Kooyk Y. Subset of DC-SIGN(+) Dendritic Cells in Human Blood Transmits HIV-1 to T Lymphocytes. Blood (2002) 100:1780–6. doi: 10.1182/blood-2001-12-0179

CrossRef Full Text | Google Scholar

64. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its Receptors to Dendritic Cell-T Cell Junctions. Science (2003) 300:1295–7. doi: 10.1126/science.1084238

CrossRef Full Text | Google Scholar

65. Klena J, Zhang P, Schwartz O, Hull S, Chen T. The Core Lipopolysaccharide of Escherichia Coli is a Ligand for the Dendritic-Cell-Specific Intercellular Adhesion Molecule Nonintegrin CD209 Receptor. J Bacteriol (2005) 187:1710–5. doi: 10.1128/JB.187.5.1710-1715.2005

CrossRef Full Text | Google Scholar

66. Zhang P, Schwartz O, Pantelic M, Li G, Knazze Q, Nobile C, et al. DC-SIGN (CD209) Recognition of Neisseria Gonorrhoeae is Circumvented by Lipooligosaccharide Variation. J Leukoc Biol (2006) 79:731–8. doi: 10.1189/jlb.0405184

CrossRef Full Text | Google Scholar

67. Zhang P, Snyder S, Feng P, Azadi P, Zhang S, Bulgheresi S, et al. Role of N-Acetylglucosamine Within Core Lipopolysaccharide of Several Species of Gram-Negative Bacteria in Targeting the DC-SIGN (CD209). J Immunol (2006) 177:4002–11. doi: 10.4049/jimmunol.177.6.4002

CrossRef Full Text | Google Scholar

68. Njiri Adhiambo O, Zhang X, Zhang Y, Wu B, Jiang L, Li Q, et al. CD209 C-Type Lectins Promote Host Invasion, Dissemination, and Infection of Toxoplasma Gondii. Front Immunol (2020) 11:656. doi: 10.3389/fimmu.2020.00656

CrossRef Full Text | Google Scholar

69. Zhang Y, Zhang S, He Y, Sun Z, Cai W, Lv Y, et al. Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic Escherichia Coli During Urinary Tract Infections. Front Cell Infect Microbiol (2020) 9:457. doi: 10.3389/fcimb.2019.00457

CrossRef Full Text | Google Scholar

70. Xue Y, Li Q, Park Chae G, Klena JD, Anisimov AP, Sun Z, et al. Proteus Mirabilis Targets Atherosclerosis Plaques in Human Coronary Arteries via DC-SIGN (CD209). Front Immunol (2021) 11:579010. doi: 10.3389/fimmu.2020.579010

CrossRef Full Text | Google Scholar

71. Zhang J, Li G, Bafica A, Pantelic M, Zhang P, Broxmeyer H, et al. Neisseria Gonorrhoeae Enhances Infection of Dendritic Cells by HIV Type 1. J Immunol (2005) 174:7995–8002. doi: 10.4049/jimmunol.174.12.7995

CrossRef Full Text | Google Scholar

Keywords: Yersinia pestis, Salmonella enterica, DEC-205 (CD205), PgtE, dissemination, evolution

Citation: Li Q, Ye C, Zhao F, Li W, Zhu S, Lv Y, Park CG, Zhang Y, Jiang L-Y, Yang K, He Y, Cai H, Zhang S, Ding H-H, Njiri OA, Tembo JM, Alkraiem AA, Li A-Y, Sun Z-Y, Li W, Yan M-Y, Kan B, Huo X, Klena JD, Skurnik M, Anisimov AP, Gao X, Han Y, Yang R-F, Xiamu X, Wang Y, Chen H, Chai B, Sun Y, Yuan J and Chen T (2022) PgtE Enzyme of Salmonella enterica Shares the Similar Biological Roles to Plasminogen Activator (Pla) in Interacting With DEC-205 (CD205), and Enhancing Host Dissemination and Infectivity by Yersinia pestis. Front. Immunol. 13:791799. doi: 10.3389/fimmu.2022.791799

Received: 09 October 2021; Accepted: 22 February 2022;
Published: 24 March 2022.

Edited by:

Gee W. Lau, University of Illinois at Urbana-Champaign, United States

Reviewed by:

Rachel M. Olson, University of Missouri, United States
Luchang Zhu, Houston Methodist Research Institute, United States

Copyright © 2022 Li, Ye, Zhao, Li, Zhu, Lv, Park, Zhang, Jiang, Yang, He, Cai, Zhang, Ding, Njiri, Tembo, Alkraiem, Li, Sun, Li, Yan, Kan, Huo, Klena, Skurnik, Anisimov, Gao, Han, Yang, Xiamu, Wang, Chen, Chai, Sun, Yuan and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tie Chen,chentie@hust.edu.cn, tiechen@charter.net; Jingping Yuan,yuanjingping@whu.edu.cn; Yicheng Sun, sunyc@ipbcams.ac.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.